by TractManager | Apr 20, 2022 | Publications
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Bulkamid (Axonics Inc.) for women with stress urinary incontinence for improvement of urinary incontinence...
by TractManager | Apr 19, 2022 | Publications
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of liposuction for improvement of pain, disability, and quality of life for patients with lipedema while reducing the...
by TractManager | Apr 18, 2022 | Emerging Technology Report
Pyrukynd (mitapivat) is an oral pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Apr 13, 2022 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment is to evaluate the safety and effectiveness of Impella devices for hemodynamic support during high-risk percutaneous coronary intervention (HRPCI).Technology Description: The Impella 2.5, Impella CP...
by TractManager | Apr 13, 2022 | News
The U.S. Food and Drug Administration (FDA) issued a letter to healthcare providers regarding the intended use of radiological computer-aided triage and notification (CADt) devices for intracranial large vessel occlusion (LVO). LVO is an obstruction of 1 of the large...
Recent Comments